The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest gastric cancer drugs market share, and Middle East was the fastest-growing region in 2022.

The global gastric cancer drugs market is expected to grow from $3.02 billion in 2022 to $3.38 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The global gastric cancer drugs market size is expected to grow to $5.03 billion in 2027 at a CAGR of 10.5%.

Major Driver In The Gastric Cancer Drugs Market ­– Increase In Several Cases Of Gastric Cancer
According to the American Institute for Cancer Research, approximately 27,600 cases of stomach cancer will be detected in 2020 (16,980 in men and 10,620 in women). A rise in the number of cases of stomach cancer will fuel the market for gastric cancer medications.

View More On The Gastric Cancer Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Key Gastric Cancer Drugs Market Segments
1) By Type: Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab
2) By End User: Hospitals, Clinics, Other End-users
3) By Route of Administration: Oral, Parenteral

Recent Gastric Cancer Drugs Market Trend – Adopting Combination Therapies
Combination medicines are being used by many firms to treat stomach cancer. Combination treatments, which treat patients with two or more medications for a single condition, improve patient care. For example, in January 2021, AstraZeneca PLC., a UK-based pharmaceutical and biotechnology company, announced that Enhertu (trastuzumab deruxtecan) was approved by the Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinomas who had previously received a trastuzumab-based regimen. Patients with advanced gastric cancer or GEJ adenocarcinoma are given trastuzumab in combination with fluoropyrimidine- and platinum-based treatment.

Gastric Cancer Drugs Market Prominent Players
Major players in the gastric cancer drugs market are Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche, GlaxoSmithKline PLC., Bristol-Myers Squibb, Sanofi, Pfizer Inc., AstraZeneca, Bayer Healthcare, Abbott, AROG Pharmaceuticals, Ipsen Biopharmaceuticals, Array Biopharma, Taiho Oncology, AstraZeneca, ARIAD Pharmaceuticals, Ono Pharmaceutical, Jiangsu HengRui Medicine, Gilead Bioscience, Celgene/Taiho, Boston Biomedical, Imugene Limited, Boehringer Ingelheim, Daiichi-Sankyo, Danaher corporation.

Request A Sample Of The Global Gastric Cancer Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2603&type=smp

The Gastric Cancer Drugs Global Market Report 2023  provides a comprehensive overview on the gastric cancer drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the gastric cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Anti-cancer treatments given orally as pills or injected into a vein (through an IV line or central venous catheter) are referred to as gastric cancer drugs. Because these treatments permeate the bloodstream and reach every area of the body, they are beneficial for cancer that has spread to organs other than those where it began.

View More Related Reports –
Cancer Biologics Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
Drugs For Hormonal Replacement Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model